Search

Your search keyword '"Stanley, Daphne A."' showing total 26 results

Search Constraints

Start Over You searched for: Author "Stanley, Daphne A." Remove constraint Author: "Stanley, Daphne A."
26 results on '"Stanley, Daphne A."'

Search Results

1. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

2. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

4. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

5. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

6. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

7. A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates

8. Supplemental Materials for Safety and Immunogenicity of Chimpanzee Adenovirus Vector Ebola Vaccine

9. Supplement to: A recombinant vesicular stomatitis virus Ebola vaccine.

10. Chimpanzee Adenovirus Vector Ebola Vaccine

11. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

12. Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP Vaccine

13. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

14. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

15. EBOLA VIRUS: Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

16. cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

17. Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates

18. Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report

19. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

20. Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques

21. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

22. Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

23. Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species

24. A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA

25. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

26. A Single-shot ChAd3 Vaccine Provides Protection from Intramuscular and Aerosol Sudan Virus Exposure.

Catalog

Books, media, physical & digital resources